Pharmacokinetic and Pharmacodynamic Profiles of Glyco-Modified Atrial Natriuretic Peptide Derivatives Synthesized Using Chemo-enzymatic Synthesis Approaches-Reference-Cited by-同舟云学术

Pharmacokinetic and Pharmacodynamic Profiles of Glyco-Modified Atrial Natriuretic Peptide Derivatives Synthesized Using Chemo-enzymatic Synthesis Approaches

Published:2018-08-03 Issue:8 Volume:29 Page:2829-2837
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Iwamoto Mitsuhiro¹^ORCID,Yamaguchi Takahiro¹,Sekiguchi Yukiko¹,Oishi Shohei¹,Shiiki Takeshi¹,Soma Masako¹,Nakamura Kensuke¹,Yoshida Makoto¹,Chaya Hiroyuki¹,Mori Yutaka¹,Miyauchi Ryuki¹,Hasegawa Jun¹,Nagayama Takahiro¹,Honda Takeshi¹

Affiliation:

1. Daiichi Sankyo Co., Ltd., 1-2-58, Hiromachi, Sinagawa-ku, Tokyo 140-8710, Japan

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.8b00427

Reference24 articles.

1. Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP)

2. Natriuretic peptides and cardio-renal disease

3. Atrial natriuretic peptide prevents cancer metastasis through vascular endothelial cells